Skip Navigation
Skip to contents

Orbitsymposium 2020

4th International Orbital Society Symposium
in conjunction with the 17th Samsung Oculoplastic Symposium
December 2(Fri.) - 3(Sat.), 2022
Conrad Hotel, Seoul,Korea

Scientific Program

HOME > Program >Scientific Program

*Please note the schedule is subject to change.

08:00-09:10 Lessons Learned from Challenging Cases
Sehyun Baek (Korea) Hirohiko Kakizaki (Japan) Diego Strianese (Italy)
08:00-08:07 Frequency of Eschar in Invasive Orbital Fungal Disease Louise A Mawn (USA)
08:07-08:14 Orbital Mucormycosis in Immunocompetent Patient Following SARS-CoV-2 Vaccination Diego Strianese (Italy)
08:14-08:21 Intraosseous Orbital Cavernous Hemangioma - Challenges in Its Management Kasturi Bhattacharjee (India)
08:21-08:28 The Management Approaches to Dacryoceles and Their Orbital Expansion Pelin Kaynak (Turkey)
08:28-08:35 Nasolacrimal Duct Obstruction in Patient with Meningoencephalocele: An Approach to Have A Successful Surgery Yunia Irawati (Indonesia)
08:35-08:42 Notorious Masses in and around the Orbit. Cases Discussion Rohit Saiju (Nepal)
08:42-08:49 Treatment of a Pediatric Case of Orbital Desmoid-type Fibromatosis with Sorafenib Cat N Burkat (USA)
08:49-08:56 Ophthalmic Manifestations and Visual Outcomes of Granulomatosis with Polyangiitis Hokyung Choung (Korea)
08:56-09:10 DISCUSSION
09:10-10:25 Thyroid Eye Disease 1 (Medical)
Helen Lew (Korea) Gangadhara Sundar (Singapore) Raymond Douglas (USA)
09:10-09:20 Thyroid Carcinoma and Thyroid Eye Disease Lay Leng Seah (Singapore)
09:20-09:35 Teprotumumab in the Treatment of TED Raymond Douglas (USA)
09:35-09:45 Thyroid Eye Disease with Compressive Optic Neuropathy: Visual Field Loss Classification and Nomenclature Suzanne K Freitag (USA)
09:45-09:57 Dysthyroid Optic Neuropathy Peerooz Saeed (Netherlands)
09:57-10:04 Novel Biomarkers in Thyroid Eye Disease Jin Sook Yoon (Korea)
10:04-10:11 Intraorbital Injections in the Management of TED Essam El Toukhy (Egypt)
10:11-10:25 DISCUSSION
10:25-10:55 BREAK
10:55-11:45 Thyroid Eye Disease 2 (Surgical)
Sang-Duck Kim (Korea) Essam El Toukhy (Egypt) Don O Kikkawa (USA)
10:55-11:05 Indication and Functional Outcome of Orbital Decompression in Thyroid Eye Disease Christoph Hintschich (Germany)
11:05-11:15 Optimizing Outcome of Orbital Decompression using Stereotactic Navigation Reynaldo Javate (Philippines)
11:15-11:25 Unbalanced Orbital Decompression Milind Naik (India)
11:25-11:35 Surgical Options for Deep Lateral Wall Decompression Marco Sales-Sanz (Spain)
11:35-11:45 DISCUSSION
11:45-13:00 Orbital Tumors 2
Wha-Sun Chung (Korea) Ashok K Grover (India) Geoffrey Rose (UK)
11:45-11:55 Decision Trees in Management of Orbital Malignancy – Towards a Logical Approach to These Tumours Geoffrey Rose (UK)
11:55-12:05 Five Concepts of Periocular Non-Hodgkin Lymphoma Jurij R Bilyk (USA)
12:05-12:15 Management of Orbital Perineural Spread of SCC Dinesh Selva (Australia)
12:15-12:25 Optic Pathway Gliomas: A Non-neurosurgical Approach to Debulking Alone William R Katowitz (USA)
12:25-12:35 Enlarged One Muscle: What Should We Know? Kyung In Woo (Korea)
12:35-12:45 Malignant Lacrimal Sac Tumors: Diagnosis and Management Chieh-Chih Tsai (Taiwan)
12:45-13:00 DISCUSSION
13:00-14:00 LUNCH
14:00-15:40 Lacrimal Gland Malignancy
Sang In Khwarg (Korea) Santosh G Honavar (India) Bita Esmaeli (USA)
14:00-14:07 Lacrimal Gland Pleomorphic Adenoma and Malignant Epithelial Tumours: Clinical and Imaging Differences Stephanie Ming Young (Singapore)
14:07-14:17 Pathology of Unusual Malignant Lacrimal Gland Tumors Steffen Heegaard (Denmark)
14:17-14:27 Considerations for the Treatment of Carcinoma Ex-Pleomorphic Adenoma James A Garrity (USA)
14:27-14:37 Bascom Palmer Experience with Lacrimal Gland Adenoid Cystic Carcinoma Wendy Lee (USA)
14:37-14:44 Lacrimal Gland Carcinoma : Why Exenteration Does Not Appear to Improve the Outcome Geoffrey Rose (UK)
14:44-14:54 Particle Therapy for Adenoid-Cystic Carcinoma of the Lacrimal Gland. Outcome Comparison Between Neutron-, Proton, and Carbon Ion-Therapy. Eugen B Hug (Austria)
14:54-15:24 Eye-preserving Combined-Modality Treatment for Adenoid Cystic Carcinoma of the Lacrimal Gland Norbert Liebsch (USA)
15:24-15:40 DISCUSSION
15:40-16:00 BREAK
16:00-17:20 Challenges and Future in the Management of Orbital Diseases
Sang Yeol Lee (Korea) Chai Teck Choo (Singapore) Peter Dolman (Canada)
16:00-16:10 Endoscopic Removal of Small Optic Apical Cavernous Hemangioma Wencan Wu (China)
16:10-16:20 360 Degree Circumferential Endoscopic Approaches to the Orbital Apex Lesions Doo Sik Kong (Korea)
16:20-16:30 Gamma Knife Radiosurgery for Orbital Apical Lesions Ho Jun Seol (Korea)
16:30-16:40 Orbital Magnets for Intractable Nystagmus: World First David Verity (UK)
16:40-16:52 Targeted Therapies in Orbital Disease Timothy Sullivan (Australia)
16:52-17:02 The Use of Immunotherapy for Locally Advanced Orbital and Adnexal Cancers Bita Esmaeli (USA)
17:02-17:20 DISCUSSION
Copyright©orbitsymposium2022. All Rights Reserved.
E-mail : |